Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 167Recruiting 123Unknown 70Terminated 51Not yet recruiting 39Active not recruiting 20Withdrawn 8Suspended 2Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 5Carcinoma, Non-Small-Cell Lung 3Solid Tumor 2Retinoblastoma 2Mesothelioma 2Advanced Solid Tumor 2von Willebrand Disease, Type 3 1beta-Thalassemia 1Xanthomatosis, Cerebrotendinous 1X-Linked Combined Immunodeficiency Diseases 1Wolman Disease 1Waardenburg syndrome type 2A 1Waardenburg syndrome type 2 1Waardenburg Syndrome 1VLCAD deficiency 1Usher syndrome, type 1F 1Usher syndrome, type 1C 1Usher syndrome, type 1B 1Tyrosinemias 1Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Triple Negative Breast Neoplasms 1Trifunctional Protein Deficiency With Myopathy And Neuropathy 1Thyroid Dyshormonogenesis 6 1Thyroid Dyshormonogenesis 5 1Thyroid Dyshormonogenesis 3 1Thyroid Dyshormonogenesis 2A 1Thyroid Dyshormonogenesis 1 1Thymus Neoplasms 1Thymoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Advanced Solid Tumors × Other solid neoplasm × Clear all
NCT07053904 2025-07-08

Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors

PharmaEssentia

Phase 1 Enrolling by invitation
54 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡